FRAXA Research Foundation... Established, 1994
Katie Clapp, MS - President and Co-Founder
In 1994, after her son Andy was diagnosed with Fragile X, Katie, her husband Michael Tranfaglia, and a third parent, Kathy May, founded FRAXA. Katie has a BA in History from Harvard and a Masters degree in Computer Science from UNC Chapel Hill. She worked as a software engineer and instructor in computer science before FRAXA. She has won some prizes for her work with FRAXA, including an American Red Cross Community Hero award and a Women of Justice award from Massachusetts Lawyers Weekly.
Michael Tranfaglia, MD - Medical Director, Treasurer, Co-Founder
Dr. Tranfaglia serves as Medical Director and Chief Scientific Officer of FRAXA. He coordinates the Foundation’s research strategy, working with academic and pharma scientists to develop new treatments for Fragile X and related developmental disorders. Dr. Tranfaglia has a BA from Harvard University and studied medicine at the University of North Carolina. After obtaining his MD, he stayed at UNC for Psychiatry residency training, and then entered private practice in Newburyport, MA. Mike had specialized in the treatment of Anxiety Disorders before his son was diagnosed with Fragile X in 1992 and subsequent founding of FRAXA.